The ACC MRI pathways support GPs and nurse practitioners to make direct referrals for MRIs, for eligible patients who have had a course of active physiotherapy.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.

The Tipu Ora stop smoking service is available to anyone who resides in the Lakes district who smokes and wants help to quit. They can access free face to face behavioural support to stop smoking, and access free nicotine replacement therapy (NRT) from the service.

The ACC MRI pathways support GPs and nurse practitioners to make direct referrals for MRIs, for eligible patients who have had a course of active physiotherapy.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.

The ACC MRI pathways support GPs and nurse practitioners to make direct referrals for MRIs, for eligible patients who have had a course of active physiotherapy.

A funded initial consult is available for eligible unenrolled Taranaki patients wanting to enrol with a Pinnacle general practice.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.

This service is delivered by Occupational Therapy Community Solutions (OTCS) and provides a driving assessment to determine fitness to drive.

The Tui Ora stop smoking service is available to anyone who resides in Taranaki who smokes and wants help to quit. They can access free face to face behavioural support to stop smoking, and access free nicotine replacement therapy (NRT) from the service.

The ACC MRI pathways support GPs and nurse practitioners to make direct referrals for MRIs, for patients who have had a course of active physiotherapy.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community. The infusion is to be provided in the community by the patient’s general practice